Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335075
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2006-06-06
Brief Title:
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma Study P03644
Sponsor:
Organization:
Merck Sharp Dohme LLC